SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-12-225917
Filing Date
2012-05-10
Accepted
2012-05-10 17:14:00
Documents
10
Period of Report
2012-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d342399d10q.htm 10-Q 432096
2 FIRST LOAN MODIFICATION AGREEMENT d342399dex102.htm EX-10.2 17867
3 CERTIFICATION d342399dex311.htm EX-31.1 8705
4 CERTIFICATION d342399dex312.htm EX-31.2 8812
5 CERTIFICATION d342399dex321.htm EX-32.1 4882
  Complete submission text file 0001193125-12-225917.txt   1992336

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT sgnt-20120331.xml EX-101.INS 241834
7 XBRL TAXONOMY EXTENSION SCHEMA sgnt-20120331.xsd EX-101.SCH 11623
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE sgnt-20120331_cal.xml EX-101.CAL 38367
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE sgnt-20120331_lab.xml EX-101.LAB 125706
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sgnt-20120331_pre.xml EX-101.PRE 78590
Mailing Address 1901 NORTH ROSELLE ROAD, SUITE 700 SCHAUMBURG IL 60195
Business Address 1901 NORTH ROSELLE ROAD, SUITE 700 SCHAUMBURG IL 60195 847-908-1604
Sagent Pharmaceuticals, Inc. (Filer) CIK: 0001369786 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: 10-Q | Act: 34 | File No.: 001-35144 | Film No.: 12831296
SIC: 2834 Pharmaceutical Preparations